Turning healthy trials into a predictable pipeline
Trials are healthy but revenue is flat. You are buying more traffic every quarter and wondering why nothing compounds. The instinct is to spend more at the top of the funnel.
Your activation data, onboarding flow, trial-to-paid conversion, and where users drop off before the product becomes useful. Usually acquisition is not the problem — activation is.
- We will reposition around the outcome rather than the feature set
- We will rebuild onboarding around a single activation moment
- We will add lifecycle nurture that follows up on stalled trials
- We will measure against activated accounts, not raw sign-ups
Same traffic, materially more activated accounts, and a pipeline you can finally forecast — with spend going down, not up.